ArticleCureus2024

Effectiveness and Toxicity Profile of Reduced Dose Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Single Institutional Experience.

Abhilash Menon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.